Clinical trial NCT03614572: Advancing Adolescent Bedtime by MI and Text Reminders
Official title: Advancing Adolescent Bedtime by Using Motivational Interviewing and Text Reminders - A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Sleep Deprivation
Keywords: Sleep deprivation
Motivational Interviewing
Text reminders
Lead sponsor: Chinese University of Hong Kong
Sponsor class: OTHER
Collaborators: name: The University of Hong Kong
First posted: 2018-08-03
Enrollment: 212
Sex: ALL
Minimum age (years): 12
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: Chronic sleep deprivation among adolescents is a prevalent health problem across the world and is associated with a series of short and long term consequences. However, effective interventions targeting on this vulnerable adolescent population is very limited. Majority of the previous sleep education programme are conducted in a school context which personal factors and individualized problems were not addressed. In addition, failure to address "knowledge-action gap" may also explain why individual fail to enact health behaviors even holding positive motivation. In regard to this, investigators proposed an active and person-oriented protocol with the aid of advanced technology in order to improve adolescent sleep health.

Detailed description: This study will conduct a randomized control trial to evaluate the effectiveness of group-based sleep intervention using motivational interviewing plus text reminders in changing adolescent sleep deprivation problem with both subjective and objective measurements. The intervention will consists of 4 weekly group therapy targeting on adolescent with school day sleep duration less than 7 hours.

Eligibility criteria: Inclusion Criteria:

* Chinese aged 12-18 years old
* Written informed consent of participation into the study is given by adolescents and his/her parents;
* Being able to comply with the study protocol;
* Having weekday sleep duration less than 7 hours for past 1 month as reported by questionnaire and average of \<7hr weekday sleep as reported by sleep diary as an indication of chronic sleep deprivation status.
* Possess a mobile phone

Exclusion Criteria:

* A current or past history of neuropsychiatric disorder(s);
* A prominent medical condition or taking medication with potential side effects that may influence sleep quantity and quality
* Having a clinical sleep disorder that may potentially contribute to the disruption of sleep quantity and quality as ascertained by both Structured Diagnostic Interview for Sleep patterns and Disorders such as insomnia, delayed sleep phase and narcolepsy.
* have enrolled in any intervention programme that may affect their sleep patterns in the past three months or are planning to join intervention programme in the next three month

Primary outcomes:
measure: Change of Sleep duration by sleep diary
timeFrame: Baseline, 1 week, 3 month and 6 month after treatment
measure: Change of Sleep duration by actigraphy
timeFrame: Baseline, 1 week, 3 month and 6 month after treatment
Secondary outcomes:
measure: Change of Sleep knowledge
timeFrame: Baseline, 1 week, 3 month and 6 month after treatment
measure: Change of Daytime Sleepiness
timeFrame: Baseline, 1 week, 3 month and 6 month after treatment
measure: Change of Quality of Life
timeFrame: Baseline, 1 week, 3 month and 6 month after treatment
measure: Change of Sleep Hygiene
timeFrame: Baseline, 1 week, 3 month and 6 month after treatment
measure: Change of Anxiety and depressive symptoms
timeFrame: Baseline, 1 week, 3 month and 6 month after treatment
measure: Change of Academic performance
timeFrame: Baseline, 3 month and 6 month after treatment
measure: Change of objective cognitive performance (inhibitory ability)
timeFrame: Baseline, 3 month and 6 month after treatment
measure: Change of objective cognitive performance (working memory by digit span)
timeFrame: Baseline, 3 month and 6 month after treatment
measure: Change of objective cognitive performance (working memory by N-Back)
timeFrame: Baseline, 3 month and 6 month after treatment
measure: Change of risk-taking & decision making
timeFrame: Baseline, 3 month and 6 month after treatment
Other outcomes:
Locations:
city: Sha Tin
country: Hong Kong
facility: Department of Psychiatry
Study officials:
affiliation: Chinese University of Hong Kong
name: Ngan Yin Chan, Mphi
role: PRINCIPAL_INVESTIGATOR
References: